169 related articles for article (PubMed ID: 17388662)
21. Long-term highly active antiretroviral therapy in chronic HIV-1 infection: evidence for reconstitution of antiviral immunity.
Jansen CA; Piriou E; De Cuyper IM; van Dort K; Lange JM; Miedema F; van Baarle D
Antivir Ther; 2006; 11(1):105-16. PubMed ID: 16518966
[TBL] [Abstract][Full Text] [Related]
22. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
[TBL] [Abstract][Full Text] [Related]
23. Epstein Barr virus genotypes and LMP-1 variants in HIV-infected patients.
Correa RM; Fellner MD; Durand K; Redini L; Alonio V; Yampolsky C; Colobraro A; Sevlever G; Teyssié A; Benetucci J; Picconi MA
J Med Virol; 2007 Apr; 79(4):401-7. PubMed ID: 17311329
[TBL] [Abstract][Full Text] [Related]
24. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
Hudnall SD; Patel J; Schwab H; Martinez J
Cytometry B Clin Cytom; 2003 Sep; 55(1):22-8. PubMed ID: 12949956
[TBL] [Abstract][Full Text] [Related]
25. Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load.
Tilton JC; Luskin MR; Johnson AJ; Manion M; Hallahan CW; Metcalf JA; McLaughlin M; Davey RT; Connors M
J Virol; 2007 Mar; 81(6):2713-25. PubMed ID: 17182676
[TBL] [Abstract][Full Text] [Related]
26. Resolution of EBV(+) CNS lymphoma with appearance of CSF EBV-specific T cells.
de Beukelaar JW; van Arkel C; van den Bent MJ; van't Veer MB; van Doornum GJ; Cornelissen JJ; Sillevis Smitt PA; Gratama JW
Ann Neurol; 2005 Nov; 58(5):788-92. PubMed ID: 16240354
[TBL] [Abstract][Full Text] [Related]
27. Plasma Epstein-Barr Virus Load as an Early Biomarker and Prognostic Factor of Human Immunodeficiency Virus-related Lymphomas.
Muncunill J; Baptista MJ; Hernandez-Rodríguez Á; Dalmau J; Garcia O; Tapia G; Moreno M; Sancho JM; Martínez-Picado J; Feliu E; Mate JL; Ribera JM; Navarro JT
Clin Infect Dis; 2019 Feb; 68(5):834-843. PubMed ID: 29982484
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus-associated primary central nervous system lymphoma in the Japanese population.
Kitai R; Matsuda K; Adachi E; Saito Y; Nakajima T; Takeuchi H; Sato K; Imamura Y; Kubota T
Neurol Med Chir (Tokyo); 2010; 50(2):114-8. PubMed ID: 20185874
[TBL] [Abstract][Full Text] [Related]
29. Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study.
Liu ZY; Guo FP; Han Y; Qiu ZF; Zuo LY; Li YL; Li TS
Chin Med J (Engl); 2009 Oct; 122(20):2497-502. PubMed ID: 20079166
[TBL] [Abstract][Full Text] [Related]
30. Cytomorphology of primary CNS lymphoma: review of 23 cases and evidence for the role of EBV.
Yu GH; Montone KT; Frias-Hidvegi D; Cajulis RS; Brody BA; Levy RM
Diagn Cytopathol; 1996 Mar; 14(2):114-20. PubMed ID: 8964166
[TBL] [Abstract][Full Text] [Related]
31. Increased susceptibility to HIV-1 of peripheral blood lymphocytes in acute infection with Epstein-Barr virus.
Moriuchi M; Moriuchi H
J Med Virol; 2003 Nov; 71(3):343-6. PubMed ID: 12966538
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
[TBL] [Abstract][Full Text] [Related]
33. High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy.
Miller CS; Berger JR; Mootoor Y; Avdiushko SA; Zhu H; Kryscio RJ
J Clin Microbiol; 2006 Jul; 44(7):2409-15. PubMed ID: 16825357
[TBL] [Abstract][Full Text] [Related]
34. The predictive value of cerebrospinal fluid Epstein-Barr viral load as a marker of primary central nervous system lymphoma in HIV-infected persons.
Corcoran C; Rebe K; van der Plas H; Myer L; Hardie DR
J Clin Virol; 2008 Aug; 42(4):433-6. PubMed ID: 18455472
[TBL] [Abstract][Full Text] [Related]
35. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
French M; Keane N; McKinnon E; Phung S; Price P
HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
[TBL] [Abstract][Full Text] [Related]
36. Effect of anal epidermoid cancer-related viruses on the dendritic (Langerhans') cells of the human anal mucosa.
Sobhani I; Walker F; Aparicio T; Abramowitz L; Henin D; Cremieux AC; Soule JC
Clin Cancer Res; 2002 Sep; 8(9):2862-9. PubMed ID: 12231528
[TBL] [Abstract][Full Text] [Related]
37. Presence of Epstein-Barr virus, cytomegalovirus and human papillomavirus in normal oral mucosa of HIV-infected and renal transplant patients.
Ammatuna P; Campisi G; Giovannelli L; Giambelluca D; Alaimo C; Mancuso S; Margiotta V
Oral Dis; 2001 Jan; 7(1):34-40. PubMed ID: 11354920
[TBL] [Abstract][Full Text] [Related]
38. Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy.
Torti C; Prosperi M; Motta D; Digiambenedetto S; Maggiolo F; Paraninfo G; Ripamonti D; Cologni G; Fabbiani M; Caputo SL; Sighinolfi L; Ladisa N; El-Hamad I; Quiros-Roldan E; Frank I
Clin Microbiol Infect; 2012 May; 18(5):449-58. PubMed ID: 21919996
[TBL] [Abstract][Full Text] [Related]
39. CD4+ and CD8+ T-cell kinetics in aviremic HIV-infected patients developing Hodgkin or non-Hodgkin lymphoma.
Hoffmann C; Schommers P; Wolf E; Müller M; Schultze A; Krznaric I; Stoehr A; Wolf T; Fäktenheuer G; Stier B; Wyen C; Hentrich M
AIDS; 2016 Mar; 30(5):753-60. PubMed ID: 26605513
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus infects B and non-B lymphocytes in HIV-1-infected children and adolescents.
Bekker V; Scherpbier H; Beld M; Piriou E; van Breda A; Lange J; van Leth F; Jurriaans S; Alders S; Wertheim-van Dillen P; van Baarle D; Kuijpers T
J Infect Dis; 2006 Nov; 194(9):1323-30. PubMed ID: 17041860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
